PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
Detalls del Canal
PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support c...
Episodis Recents
535 episodis
Nicola Gökbuget, MD - Moving Forward in B-ALL: Insights on Modern and Emerging Standards With Off-the-Shelf Bispecific Antibodies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Stephen V. Liu, MD - Innovation Takes the Lead in SCLC: Leveraging Evolving Advances to Drive Improved Outcomes in Limited- and Extensive-Stage Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Benjamin C. Creelan, MD - Taking the High Road in NSCLC: Navigating Through Immunotherapy-Based Treatments to Optimize Outcomes
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Dr. Martin Dreyling - Redrawing Frontlines in MCL: The Upfront Expansion of BTKi Options and Modern Clinical Decision-making in Newly Diagnosed Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Sagar Lonial, MD, FACP - Many Roads to Myeloma Remission: Making Sequential Choices With BCMA and Non-BCMA Immunotherapies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Guillermo Garcia-Manero, MD - MASTER MDS for Enhanced Patient Care: Modern Advances With Standard and Emerging Risk-Adapted Treatment
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Noel Clarke, MBBS, FRCS ChM / Joaquin Mateo, MD, PhD / Isabela Werneck da Cunha, MD, PhD, MBA - New Kids on the Block in mHSPC: Personalising Approaches Through Emerging Precision Therapies
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Zachariah DeFilipp, MD - Rising to the Graft-vs-Host Disease Challenge: Progress in Treatment and Post-HCT Outcomes Across Hematologic Cancers
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Jennifer Woyach, MD - Revealing New Sequences in CLL: Collaborative Care Planning With Real-World Evidence and Modern Therapeutics
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Joyce O'Shaughnessy, MD - Forging New Paths With Earlier Use of ADCs in Breast Cancer: From Clinical Breakthroughs to Improved Outcome
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
David A. Sallman, MD - Menin Masters for AML Care: Guidance on Integrating Menin Inhibitor Regimens and Boosting Efficacy in Challenging AML Subtypes
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Professor John G. Gribben, MD, DSc - Pathways to Personalized Remission in CLL: Leveraging Targeted Standards and Next-Gen Advances for Upfront and Sequential Care
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Dr. Max S. Topp, MD - Off the Shelf and in the Clinic for NHL: Leveraging Bispecific Antibody Strategies in DLBCL, FL, and Beyond
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Komal Jhaveri, MD, FACP - Dialing Up Precision in HR+, HER2- MBC With New Endocrine Agents, Targeted Therapies, and Combinations: A Framework for Multifactorial Clinical Decisions
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Eric Van Cutsem, MD, PhD - Precision Tactics With HER2-Targeting ADCs in HER2-Altered Solid Tumors: Candid Conversations and Clinical Consults
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Sia Daneshmand, MD - Elevating NMIBC Care: Putting the Latest Innovations for Intravesical Therapies Into Practice
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Solange Peters, MD, PhD / Prof. David Planchard, MD, PhD - The Challenges of Choice in First-Line EGFRm NSCLC: Practical Guidance on Optimising Treatment Approaches
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Barbara Burtness, MD / Ravindra Uppaluri, MD, PhD, FACS - Definitive Innovation in Resectable Head and Neck Cancer: New Immunotherapy Approaches in LA-HNSCC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Ibiayi Dagogo-Jack, MD, FASCO, Van Karlyle Morris, MD - Calibrating Clinical Approaches for Metastatic Colorectal and Lung Cancers: Insights on Molecular Testing and BRAF Inhibitors in Community Settings
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Fred Saad, CQ, MD, FRCS, FCAHS - Innovative Approaches in Prostate Cancer: Bridging Genomics and Patient-Centric Treatment
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
William D. Tap, MD - Achieving Disease Control in TGCT: Critical Steps For Integrating Evidence-Based Care With CSF1R Inhibitors
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Manmeet S. Ahluwalia, MD, MBA, FASCO - Next-Generation Solutions to Optimize Glioma Care: Applying The Latest Evidence on Molecularly Targeted Therapies in IDH-Mutant Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Jonathan W. Goldman, MD - Addressing un-MET Needs in NSCLC: Elevating MET-Targeting Options for Patients With a Poor Prognosis
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Geoffrey Ku, MD - Turning the Tide in Gastric Cancer Management: Integrating Modern Systemic Therapies Across the Disease Continuum for Community-Based Clinicians
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Ciro Rinaldi, MD, PhD - Elevating Total Care for PV and ET: From Diagnostic Precision to Patient-Centred Innovation
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Dr. Konstanze Döhner - The Practicalities of Personalised Therapy in AML: The Who, How, When, and Why of Treating IDH1-Mutated Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Lynsey P. Teulings, APRN - Ahead of the Immunotherapy Curve in Head and Neck Cancer: Preparing for Expanding Immune Options in Locally Advanced and Recurrent/Metastatic Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Karen C. Daily, D.O. - RiskReady: A Systems Approach to Improving the Recognition and Treatment of High-Risk, HR+, HER2- Early Breast Cancer
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Susana Banerjee, MBBS, MA, FRCP, PhD, Ana Oaknin, MD, PhD - Putting the Puzzle Together in Advanced Ovarian and Cervical Cancers: Translating Evidence Into Practice for Approved and Emerging ADCs
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Erica L. Mayer, MD, MPH - Risk Assessment and Treatment Initiation: Successfully Jumpstarting the Adjuvant CDK4/6 Inhibitor Treatment Journey in HR+, HER2- EBC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Susana Banerjee, MBBS, MA, FRCP, PhD, Kathleen N. Moore, MD, MS - Harnessing the Power of ADCs in Gynecologic Cancers: Expert Insights for Practice Integration
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Angela Lamarca, MD, PhD, MSc - The Power of Personalised Approaches in Advanced CCA: Team-Based Strategies to Individualise Clinical Care
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Erica L. Mayer, MD, MPH - Nurturing Lasting Benefits of Adjuvant CDK4/6 Inhibitor Therapy in High-Risk HR+, HER2- EBC: Best Practices for Patient Education, AE Monitoring and Management, and Enhanced Adherence/Persistence
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Professor Stephen Johnston, MA, FRCP, PhD - Charting New Paths in the Treatment of ER+, HER2- MBC: Seeking Clarity and Consensus Through Evidence-Aligned Clinical Cases
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Yelena Y. Janjigian, MD*, Siva Raja, MD, PhD, FACS - Critical Conversations for Surgeons and Oncologists in Resectable Gastric/GEJ Cancer: Expert Guidance on Integrating Rapidly Evolving Evidence for Immunotherapy Platforms
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Nicolas Girard, MD, PhD / Pasi A. Jänne, MD, PhD - Making Precision Decisions for Patients With EGFRm NSCLC: Success Strategies With Targeted Options, Potent Combinations, and Emerging Agents
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Nikhil I. Khushalani, MD - The Immunotherapy Story Continues for CSCC: Insights and Evidence on Advances in Resectable and Unresectable Disease
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Paolo Ghia, MD, PhD - The Clock Strikes Innovation in CLL: Upfront Care With Newer, Time-Limited BTKi Combinations
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Prof. Sanjay Popat, FRCP, PhD - The Earlier the Better in Lung Cancer: Multispecialty Guidance on Screening, Diagnosis and Management of Resectable NSCLC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...
Komal Jhaveri, MD, FACP - Changing the Scenery in ER+, HER2- MBC With New Oral SERDs and Combinations: Foundations, Evidence, and Practicalities
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevan...